Rapamycin for longevity: opinion article

被引：136
作者：
Blagosklonny, Mikhail V. [1 ]
机构：
[1] Roswell Park Canc Inst, Cell Stress Biol, Buffalo, NY 14263 USA
来源：
AGING-US | 2019年 / 11卷 / 19期
关键词：
rapamycin; rapalogs; metformin; aging; anti-aging; fasting; lifespan; health span; EXTENDS LIFE-SPAN; DIABETIC KIDNEY-DISEASE; LONG-TERM TREATMENT; MAMMALIAN TARGET; DIETARY RESTRICTION; INSULIN-RESISTANCE; TRANSPLANT RECIPIENTS; CELLULAR SENESCENCE; CALORIC RESTRICTION; MTOR INHIBITION;
D O I：
10.18632/aging.102355
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
From the dawn of civilization, humanity has dreamed of immortality. So why didn't the discovery of the anti-aging properties of mTOR inhibitors change the world forever? I will discuss several reasons, including fear of the actual and fictional side effects of rapamycin, everolimus and other clinically-approved drugs, arguing that no real side effects preclude their use as anti-aging drugs today. Furthermore, the alternative to the reversible (and avoidable) side effects of rapamycin/everolimus are the irreversible (and inevitable) effects of aging: cancer, stroke, infarction, blindness and premature death. I will also discuss why it is more dangerous not to use anti-aging drugs than to use them and how rapamycin-based drug combinations have already been implemented for potential life extension in humans. If you read this article from the very beginning to its end, you may realize that the time is now.
引用
收藏
页码：8048 / 8067
页数：20
相关论文
共 202 条
[11]  
Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]
[12]  
Bjelakovic G, 2014, CURR OPIN CLIN NUTR, V17, P40, DOI 10.1097/MCO.0000000000000009
[13]   Meta-Regression Analyses, Meta-Analyses, and Trial Sequential Analyses of the Effects of Supplementation with Beta-Carotene, Vitamin A, and Vitamin E Singly or in Different Combinations on All-Cause Mortality: Do We Have Evidence for Lack of Harm? [J].
Bjelakovic, Goran ;
Nikolova, Dimitrinka ;
Gluud, Christian .
PLOS ONE, 2013, 8 (09)
[14]   Koschei the immortal and anti-aging drugs [J].
Blagosklonny, M. V. .
CELL DEATH & DISEASE, 2014, 5 :e1552-e1552
[15]   Aging ROS or TOR [J].
Blagosklonny, Mikhail V. .
CELL CYCLE, 2008, 7 (21) :3344-3354
[16]   Prevention of cancer by inhibiting aging [J].
Blagosklonny, Mikhail V. .
CANCER BIOLOGY & THERAPY, 2008, 7 (10) :1520-1524
[17]   Aging, stem cells, and mammalian target of rapamycin: A prospect of pharmacologic rejuvenation of aging stem cells [J].
Blagosklonny, Mikhail V. .
REJUVENATION RESEARCH, 2008, 11 (04) :801-808
[18]   An anti-aging drug today: from senescence-promoting genes to anti-aging pill [J].
Blagosklonny, Mikhail V. .
DRUG DISCOVERY TODAY, 2007, 12 (5-6) :218-224
[19]   Aging and immortality - Quasi-programmed senescence and its pharmacologic inhibition [J].
Blagosklonny, Mikhail V. .
CELL CYCLE, 2006, 5 (18) :2087-2102
[20]   The mystery of the ketogenic diet: benevolent pseudo-diabetes [J].
Blagosklonny, Mikhail, V .
CELL CYCLE, 2019, 18 (18) :2157-2163
12345678910